Tackling cardiovascular disease in the Asia–Pacific region: a new Lancet Commission
Date
2025
Authors
Lam, C.S.P.
Cader, F.A.
Chew, N.W.S.
Chow, C.K.
Grey, C.
Guo, Y.
Nelson, A.J.
Rolleston, A.
Sawano, M.
Tan, K.C.B.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
The Lancet, 2025; 406(10507):P988-P989
Statement of Responsibility
Carolyn S P Lama, F Aaysha Caderc, Nicholas W S Chewa, Clara K Chow, Corina Greyg, Yuming Guoh, Adam J Nelsonh, Anna Rolleston, Mitsuaki Sawanom, Kathryn Choon Beng Tann, Jasper Trompb, Lijing L Yanp, Stephen J Nicholls
Conference Name
Abstract
The Asia–Pacific region has a high global burden of cardiovascular disease.1 The region, home to more than 60% of the world's population, spans the vast and diverse geographies from Oceania through east, central, southeast, and south Asia and includes the world's most populous nations and many of its most rapidly ageing societies.2 Sociocultural, economic, and health system diversity also characterise this region. While cardiovascular disease remains the leading cause of death worldwide,3 its impact is profound in the Asia–Pacific region with crude cardiovascular mortality projected to almost double by 2050 in Asia.4 Addressing cardiovascular disease in this region is not only a local necessity, but also a global imperative.
School/Discipline
Dissertation Note
Provenance
Description
Comment/note
Access Status
Rights
© 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.